Voltarol Joint Pain Relief Gel

Voltarol is a prominent brand of topical pain relief treatments containing the active ingredient diclofenac, a non-steroidal anti-inflammatory drug (NSAID). Originally developed in Switzerland, the brand has become a global leader in the musculoskeletal pain category, widely used for treating joint pain, muscle aches, and inflammation. The product is manufactured in various pharmaceutical facilities worldwide to meet global demand, with major production sites located in Europe and North America.

The history of Voltarol is deeply tied to the Swiss pharmaceutical giant Novartis, which spearheaded its development and commercial success. However, in recent years, the ownership structure of the consumer healthcare division underwent significant changes. Following a major joint venture and subsequent demerger between GSK and Novartis, the consumer brand portfolio, including Voltarol, was transitioned into a newly formed independent company. Today, the brand is owned and managed by Haleon, one of the world's largest focused consumer health companies, which continues to distribute the product globally under various names such as Voltaren in other markets.